Dermata Sets Mid-2026 Launch of Weekly Skincare Mask, Secures $2M ATM Funding
DRMA•Dermata Therapeutics launched its new direct-to-consumer skincare brand Tome and plans a mid-2026 debut of its once-weekly Tome Foundational Treatment while hiring a VP of Marketing. The company raised $2.0 million net in Q1 ATM financing, holds $6.9 million cash, and expects runway into Q1 2027.
1. New DTC Strategy and Brand Launch
Dermata announced its strategic pivot to direct-to-consumer skincare with the launch of the Tome brand, aiming to deliver professional-grade products at home. In March 2026 the company hired Kyra Peckaitis as Vice President of Marketing to lead brand development and prepare for consumer studies ahead of product rollout.
2. Q1 2026 Financial Highlights
In the first quarter ended March 31, Dermata raised $2.0 million in net proceeds via its at-the-market financing facility and ended the period with $6.9 million in cash, down from $7.5 million at year-end. Research and development expenses fell to $0.4 million from $1.3 million year-over-year, while selling, general and administrative costs rose to $1.5 million from $1.1 million, positioning the company’s cash runway into Q1 2027.
3. Upcoming Product Pipeline
The company is finalizing packaging and conducting consumer use studies for its once-weekly Tome Foundational Treatment, targeting a mid-2026 launch to support skin renewal. Dermata is also advancing development of a second DTC product to follow the initial offering, aiming to expand its Tome skincare portfolio.
